Stressed working conditions with drastically changing lifestyles are the factors driving sedatives market growth. Rising intake of stimulating beverages such as coffee, tea & energy drinks leading to insomnia is another factor fueling the sedatives market. The growing geriatric population, rising need for therapeutic surgeries & invasive procedures with the development of new analgesic drugs are likely to drive the sedatives market in the forecasting period.
As per the latest report added by Value Market Research, the Global Sedatives Market was valued at USD 4.01 BN (by revenue) in 2022 and is anticipated to reach USD 6.15 BN by 2030 with a CAGR of 5.5%.
BENZODIAZEPINES HAVE DOMINATED THE TYPE SEGMENT
Benzodiazepine led the type segment and is anticipated to reach USD XX BN by the end of 2030. Rising anxiety disorders, stress-related conditions, insomnia, and others are the factors boosting the demand for benzodiazepines products.
NON-PEDIATRICS HAS LED THE APPLICATION SEGMENT
Non-pediatrics dominated the application segment and is likely to reach USD XX BN by the end of 2030.. Rising depression, anxiety, stress, insomnia, and mental disorder among non-pediatric population is driving the market growth.
NORTH AMERICA IS THE REGIONAL LEADER FOR THE SEDATIVES MARKET
North America has shown dominance over the segment and is presumed to reach USD XX BN by the end of 2030. North America has led the regional segment owing to changing work environment & rising health issues leading to surgeries has driven the regional market. At the same time, Asia-Pacific is an emerging regional segment owing to the rising geriatric population & rising health concerns within India & China is presumed to upsurge the sedative market growth.
KEY PLAYERS OF THE SEDATIVES MARKET
Advicenne Pharma, AstraZeneca Plc, Concert Pharmaceuticals, Inc., Drawbridge Pharmaceuticals Pty Ltd., NanoMedex Pharmaceuticals, Inc., Paion AG, Takeda Pharmaceutical, and The Medicines Company are the major players within the sedative market.